BELIMUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 16:32:36 GMT 2023` Edited by `admin` on `Sat Dec 16 16:32:36 GMT 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	73B0K5S26A
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

BELIMUMAB

Official Name

English

BELIMUMAB [PURPLE BOOK CDER]

Common Name

English

BELIMUMAB [MART.]

Common Name

English

GSK-1550188

Code

English

HGS1006

Code

English

LYMPHOSTAT-B

Brand Name

English

BELIMUMAB [MI]

Common Name

English

BELIMUMAB (GENETICAL RECOMBINATION) [JAN]

Common Name

English

BELIMUMAB [JAN]

Common Name

English

BELIMUMAB [USAN]

Common Name

English

HGS-1006

Code

English

BEL-114333

Code

English

belimumab [INN]

Common Name

English

BELIMUMAB [VANDF]

Common Name

English

BELIMUMAB [EMA EPAR]

Common Name

English

GSK1550188

Code

English

BELIMUMAB (GENETICAL RECOMBINATION)

Common Name

English

IMMUNOGLOBULIN G1, ANTI (HUMAN CYTOKINE BAFF) (HUMAN MONOCLONAL LYMPHOSTAT-B HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LYMPHOSTAT-B .LAMBDA. CHAIN, DIMER

Common Name

English

BENLYSTA

Brand Name

English

BEL114333

Code

English

Belimumab [WHO-DD]

Common Name

English

Classification Tree Code System Code

WHO-ATC

L04AA26

Created by admin on Sat Dec 16 16:32:36 GMT 2023 , Edited by admin on Sat Dec 16 16:32:36 GMT 2023

NDF-RT

N0000182637

Created by admin on Sat Dec 16 16:32:36 GMT 2023 , Edited by admin on Sat Dec 16 16:32:36 GMT 2023

FDA ORPHAN DRUG

921522

Created by admin on Sat Dec 16 16:32:36 GMT 2023 , Edited by admin on Sat Dec 16 16:32:36 GMT 2023

NCI_THESAURUS

C20401

Created by admin on Sat Dec 16 16:32:36 GMT 2023 , Edited by admin on Sat Dec 16 16:32:36 GMT 2023

WHO-VATC

QL04AA26

Created by admin on Sat Dec 16 16:32:36 GMT 2023 , Edited by admin on Sat Dec 16 16:32:36 GMT 2023

EMA ASSESSMENT REPORTS

BENLYSTA (AUTHORIZED LUPUS ERYTHEMSTOSUS, SYSTEMIC)

Created by admin on Sat Dec 16 16:32:36 GMT 2023 , Edited by admin on Sat Dec 16 16:32:36 GMT 2023

Code System Code Type Description

DRUG CENTRAL

4949

Created by admin on Sat Dec 16 16:32:36 GMT 2023 , Edited by admin on Sat Dec 16 16:32:36 GMT 2023

PRIMARY

USAN

OO-56

Created by admin on Sat Dec 16 16:32:36 GMT 2023 , Edited by admin on Sat Dec 16 16:32:36 GMT 2023

PRIMARY

WIKIPEDIA

BELIMUMAB

Created by admin on Sat Dec 16 16:32:36 GMT 2023 , Edited by admin on Sat Dec 16 16:32:36 GMT 2023

PRIMARY

IUPHAR

6887

Created by admin on Sat Dec 16 16:32:36 GMT 2023 , Edited by admin on Sat Dec 16 16:32:36 GMT 2023

PRIMARY

DAILYMED

73B0K5S26A

Created by admin on Sat Dec 16 16:32:36 GMT 2023 , Edited by admin on Sat Dec 16 16:32:36 GMT 2023

PRIMARY

FDA UNII

73B0K5S26A

Created by admin on Sat Dec 16 16:32:36 GMT 2023 , Edited by admin on Sat Dec 16 16:32:36 GMT 2023

PRIMARY

NDF-RT

N0000182156

Created by admin on Sat Dec 16 16:32:36 GMT 2023 , Edited by admin on Sat Dec 16 16:32:36 GMT 2023

PRIMARY

Decreased B Lymphocyte Activation [PE]

ChEMBL

CHEMBL1789843

Created by admin on Sat Dec 16 16:32:36 GMT 2023 , Edited by admin on Sat Dec 16 16:32:36 GMT 2023

PRIMARY

CAS

356547-88-1

Created by admin on Sat Dec 16 16:32:36 GMT 2023 , Edited by admin on Sat Dec 16 16:32:36 GMT 2023

PRIMARY

SMS_ID

100000090056

Created by admin on Sat Dec 16 16:32:36 GMT 2023 , Edited by admin on Sat Dec 16 16:32:36 GMT 2023

PRIMARY

RXCUI

1092437

Created by admin on Sat Dec 16 16:32:36 GMT 2023 , Edited by admin on Sat Dec 16 16:32:36 GMT 2023

PRIMARY

RxNorm

NDF-RT

N0000182636

Created by admin on Sat Dec 16 16:32:36 GMT 2023 , Edited by admin on Sat Dec 16 16:32:36 GMT 2023

PRIMARY

B Lymphocyte Stimulator-directed Antibody Interactions [MoA]

EVMPD

SUB25607

Created by admin on Sat Dec 16 16:32:36 GMT 2023 , Edited by admin on Sat Dec 16 16:32:36 GMT 2023

PRIMARY

MERCK INDEX

m2294

Created by admin on Sat Dec 16 16:32:36 GMT 2023 , Edited by admin on Sat Dec 16 16:32:36 GMT 2023

PRIMARY

Merck Index

INN

8381

Created by admin on Sat Dec 16 16:32:36 GMT 2023 , Edited by admin on Sat Dec 16 16:32:36 GMT 2023

PRIMARY

DRUG BANK

DB08879

Created by admin on Sat Dec 16 16:32:36 GMT 2023 , Edited by admin on Sat Dec 16 16:32:36 GMT 2023

PRIMARY

NCI_THESAURUS

C91385

Created by admin on Sat Dec 16 16:32:36 GMT 2023 , Edited by admin on Sat Dec 16 16:32:36 GMT 2023

PRIMARY

LACTMED

Belimumab

Created by admin on Sat Dec 16 16:32:36 GMT 2023 , Edited by admin on Sat Dec 16 16:32:36 GMT 2023

PRIMARY

From	To
1_22	1_96
2_22	2_96

Related Record Type Details


					U1A5T521IT

TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B MEMBRANE FORM

TARGET -> INHIBITOR

Amount:

Related Record Type Details


					73B0K5S26A

BELIMUMAB

ACTIVE MOIETY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Volume of Distribution	PHARMACOKINETIC

Biological Half-life	PHARMACOKINETIC

Molecular Formula	CHEMICAL
MOL_WEIGHT:SEQUENCE	CHEMICAL